PAREXEL International Corporation, a biopharmaceutical
outsourcing services company, provides clinical research, clinical
logistics, medical communications, consulting, commercialization, and
advanced technology products and services for pharmaceutical,
biotechnology, and medical device industries worldwide. The company
operates in three segments: Clinical Research Services (CRS), PAREXEL
Consulting Services (PC), and PAREXEL Informatics (PI).
Take a look at the 1-year chart of PAREXEL (Nasdaq: PRXL) below with added notations:
PRXL was on a steady trend higher from April up until its $64, September high. After that, the stock has hit that same $64 (blue) mark several times only to end up eventually pulling back down. If PRXL can finally break through that $64 resistance the stock should be headed higher. A close above that resistance would also constitute a new 52-week high.
The Tale of the Tape: PRXL has a 52-week resistance at $64. The possible long position on the stock would be on a breakout above that level with a stop placed under it.
Please share this article
Take a look at the 1-year chart of PAREXEL (Nasdaq: PRXL) below with added notations:
PRXL was on a steady trend higher from April up until its $64, September high. After that, the stock has hit that same $64 (blue) mark several times only to end up eventually pulling back down. If PRXL can finally break through that $64 resistance the stock should be headed higher. A close above that resistance would also constitute a new 52-week high.
The Tale of the Tape: PRXL has a 52-week resistance at $64. The possible long position on the stock would be on a breakout above that level with a stop placed under it.
No comments:
Post a Comment